UNITS PLUMMETS AFTER NOVO NORDISK DEAL BREAKDOWN

Shares of HIMS experienced a dramatic drop today following the unexpected cancellation of its partnership with pharmaceutical giant Novo Nordisk. Investors interpreted negatively to the news, sending HIMS's stock price plummeting by more than 10%. The reason for the breakdown of the partnership remains unclear, but industry analysts speculate that